Empirická antimykotická léčba febrilní neutropenie u nemocných s hematologickou malignitou - doporučení odborníků - s podporou CELL, ČHS ČLS JEP, ČOS ČLS JEP, SCHS SLS
| Title in English | Empirical antifungal therapy of febrile neutropenia in patients with hematogic malignancies - experts advice - with the support of CELL, CHS CLS JEP, COS CLS JEP, SCHS SLS |
|---|---|
| Authors | |
| Year of publication | 2010 |
| Type | Article in Periodical |
| Magazine / Source | Postgraduální medicína |
| MU Faculty or unit | |
| Citation | |
| Field | Oncology and hematology |
| Keywords | invasive fungal infection; empirical antifungal therapy; febrile neutropenia; hematologic malignancy |
| Description | Invasive fungal infections are a serious complication accompanying the treatment of hematooncological patients. Empirical use of systemic antifungal therapy is standard medical practice in granulocytopenic patients with a hematologic malignancy with fever unresponsive to broad-spectrum antibiotics. Recommendations presented below are based on the views of the European Conference on Infection in Leukemia (ECIL). They represent a consensus of experts for the selection of antifungal agents for empirical treatment of febrile neutropenia in this patient group. |